Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:2786:289-300.
doi: 10.1007/978-1-0716-3770-8_13.

Plant Expression of Trans-Encapsidated Chimeric Viral Vaccines with Animal RNA Replicons: An Update

Yiyang Zhou  1 , Alison A McCormick  2 , Christopher M Kearney  3
Affiliations

Plant Expression of Trans-Encapsidated Chimeric Viral Vaccines with Animal RNA Replicons: An Update

Yiyang Zhou et al. Methods Mol Biol. 2024.

Abstract

In this protocol, we outline how to produce a chimeric viral vaccine in a biosafety level 1 (BSL1) environment. An animal viral vector RNA encapsidated with tobacco mosaic virus (TMV) coat protein can be fully assembled in planta. Agrobacterium cultures containing each component are inoculated together into tobacco leaves and the self-assembled hybrid chimeric viral vaccine is harvested 4 days later and purified with a simple PEG precipitation. The viral RNA delivery vector is derived from the BSL1 insect virus, Flock House virus (FHV), and replicates in human and animal cells but does not spread systemically. A polyethylene glycol purification protocol is also provided to collect and purify these vaccines for immunological tests. In this update, we also provide a protocol for in trans co-inoculation of a modified FHV protein A, which significantly increased the yield of in planta chimeric viral vaccine.

Keywords: Agroinoculation; Endoplasmic reticulum (ER)-targeting; Flock House virus; Polyethylene glycol purification; Tobacco mosaic virus; Viral vaccine; Trans-encapsidation.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ndwandwe D, Wiysonge CS (2021) COVID-19 vaccines. Curr Opin Immunol 71:111–116. https://doi.org/10.1016/j.coi.2021.07.003 - DOI - PubMed - PMC
    1. Pardi N, Hogan MJ, Porter FW, Weissman D (2018) mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov 17(4):261–279. https://doi.org/10.1038/nrd.2017.243 - DOI - PubMed - PMC
    1. Maharaj PD, Mallajosyula JK, Lee G, Thi P, Zhou Y, Kearney CM, McCormick AA (2014) Nanoparticle encapsidation of flock house virus by auto assembly of tobacco mosaic virus coat protein. Int J Mol Sci 15(10):18540–18556. https://doi.org/10.3390/ijms151018540 - DOI - PubMed - PMC
    1. Zhou Y, Maharaj PD, Mallajosyula JK, McCormick AA, Kearney CM (2015) In planta production of Flock House Virus Transencapsidated RNA and its potential use as a vaccine. Mol Biotechnol 57(4):325–336. https://doi.org/10.1007/s12033-014-9826-1 - DOI - PubMed
    1. Biddlecome A, Habte HH, McGrath KM, Sambanthamoorthy S, Wurm M, Sykora MM, Knobler CM, Lorenz IC, Lasaro M, Elbers K, Gelbart WM (2019) Delivery of self-amplifying RNA vaccines in in vitro reconstituted virus-like particles. PLoS One 14(6):e0215031. https://doi.org/10.1371/journal.pone.0215031 - DOI - PubMed - PMC

LinkOut - more resources